UroGen: Upcoming PDUFA, Some Concerns Remain

Company Overview - UroGen is an uro-oncology focused company with an approved legacy product and a late-stage pipeline with an upcoming PDUFA [1] - The company develops a proprietary sustained release hydrogel technology called RTGel, designed to improve therapeutic benefits [1] Investment Tools and Support - The Total Pharma Tracker offers tools for DIY investors, including a software for entering any ticker to access extensive curated research material [2] - For investors needing hands-on support, in-house experts identify the best investible stocks, providing buy/sell strategies and alerts [2]